Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Incorporating TET2 Variant Allele Frequency Enhances Prognostication in CMML: Insights from 849 Patients across Multiple Institutions

Yu-Hung Wang, Dorothée Selimoglu-Buet, Carmelo Gurnari, Andres Jerez, Andrius Zucenka, Chi-Yuan Yao, Chien-Chin Lin, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien, Jaroslaw Maciejewski, Eric Solary, Kiran Batta, Daniel H Wiseman

Blood (2024) 144 (Supplement 1): 4579.

https://doi.org/10.1182/blood-2024-194319

Published: 2024

Journal Articles

Single-Cell Multiomic Profiling of TP53 Mutated Myelodysplastic Neoplasms - All Clones Are Not Equal

Onima Chowdhury, Kristian Gurashi, Amy Wood, Ivan Lukic, Adam Sciambi, Lynn Quek, Daniel H Wiseman, Adam J Mead

Blood (2024) 144 (Supplement 1): 3615.

https://doi.org/10.1182/blood-2024-210047

Published: 2024

Journal Articles

Granulocyte Derived Resistin Induces Classical Monocyte Repartition and Immune Suppression in CMML

Nathan J Hull, Rachel Cant, Yu-Hung Wang, Kristian Gurashi, Laura A Guest, Daniel H Wiseman, Kiran Batta

Blood (2024) 144 (Supplement 1): 880.

https://doi.org/10.1182/blood-2024-205238

Published: 2024

Journal Articles

Prediction Model to Evaluate Engraftment Kinetics Following Stem Cell Transplantation

Samar Kulkarni, Adrian Bloor, Mike Dennis, Anna Z Castleton, Mark Williams, Ahmed Abdulgawad, Tim Somervaille, Daniel H Wiseman, Vismay Deshani, Emma Searle, Angie Leather, John Murray, Sally Pickering, James Cavet

Blood (2024) 144 (Supplement 1): 3496.

https://doi.org/10.1182/blood-2024-211021

Published: 2024

Journal Articles

Fungal Blood Stream Infections (BSI) in Hematology-Oncology Patients Have Worse Outcomes Than Solid Tumour Patients

Vismay Deshani, H Hemat, Adrian Bloor, Mike Dennis, Alex Peel, Adam Jeans, Anna Z Castleton, Emma Searle, Daniel H Wiseman, Mark Williams, Richard Chasty, Ahmed Abdulgawad, Tim Somervaille, John Murray, Jane Robertson, James Cavet, Samar Kulkarni

Blood (2024) 144 (Supplement 1): 7897.

https://doi.org/10.1182/blood-2024-198526

Published: 2024

Journal Articles

Prevalence and Significance of Clonal Monocytosis of Undetermined Significance (CMUS) Amongst 431,531 United Kingdom Biobank Participants

William G Dunn, Muxin Gu, Pedro Quiros, Irina Mohorianu, Daniel H Wiseman, George S Vassiliou

Blood (2024) 144 (Supplement 1): 4048.

https://doi.org/10.1182/blood-2024-201387

Published: 2024

Journal Articles

Newly Developed Prognostic Score for Myelodysplastic Syndrome (MDS) with Isolated 5q Deletion (IPSS-del(5q))

Blood (2024) 144 (Supplement 1): 666.

https://doi.org/10.1182/blood-2024-194405

Published: 2024

Journal Articles

Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion

Blood (2024) 144 (16): 1722–1731.

https://doi.org/10.1182/blood.2024023840

Published: 2024

Includes: Supplemental data

Journal Articles

HMR Mutations Drive Poor Prognosis in Myelofibrosis Patients with Lower JAK2 V617F Allele Burden but Not in Those with Higher Allele Burden: Results of a Multicenter Study

Yu-Hung Wang, Carmelo Gurnari, Chao-Hung Wei, Hussein Awada, Chien-Chin Lin, Andrius Zucenka, Chi-Yuan Yao, Kristian Gurashi, Hsin-An Hou, Kiran Batta, Wen-Chien Chou, Jaroslaw P. Maciejewski, Daniel H Wiseman, Hwei-Fang Tien

Blood (2023) 142 (Supplement 1): 627.

https://doi.org/10.1182/blood-2023-179907

Published: 2023

Journal Articles

TP53 G ene a llelic State in Myelodysplastic Syndromes (MDS) with Isolated 5q Deletion

Blood (2023) 142 (Supplement 1): 1001.

https://doi.org/10.1182/blood-2023-179171

Published: 2023

Journal Articles

Development of Novel Protein-Drug Conjugates for the Treatment of Chronic Myelomonocytic Leukemia

Rachel Cant, Lucy Huitong Li, May-Li Mackinnon, Daniel H Wiseman, Kiran Batta, Sam Butterworth

Blood (2023) 142 (Supplement 1): 3637.

https://doi.org/10.1182/blood-2023-186657

Published: 2023

Journal Articles

Prognostic and Therapeutic Implications of TP53 expression in Chronic Myelomonocytic Leukaemia: Results of a Multicentre Study

Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Fabio Amaral, Chi-Yuan Yao, Joanna Storer, Luciano Nicosia, Bettina Wingelhofer, Hsin-An Hou, Andres Jerez, Wen-Chien Chou, Kiran Batta, Hwei-Fang Tien, Daniel H Wiseman

Blood (2023) 142 (Supplement 1): 3213.

https://doi.org/10.1182/blood-2023-180034

Published: 2023

Journal Articles

The Functional and Molecular Alterations in Human Bone Marrow Mesenchymal Stem Cells in Chronic Myelomonocytic Leukemia

Joanna A Storer, Tim C.P Somervaille, Daniel H Wiseman, Kiran Batta

Blood (2022) 140 (Supplement 1): 5782–5783.

https://doi.org/10.1182/blood-2022-166138

Published: 2022

Journal Articles

A Three Gene Leukemic Stem Cell Signature Score Is Robustly Prognostic in Chronic Myelomonocytic Leukemia

Yu-Hung Wang, Chi-Yuan Yao, Chien-Chin Lin, Kristian Gurashi, Fabio Amaral, Andres Jerez, Tim C.P Somervaille, Hsin-An Hou, Wen-Chien Chou, Kiran Batta, Hwei-Fang Tien, Daniel H Wiseman

Blood (2022) 140 (Supplement 1): 1104–1105.

https://doi.org/10.1182/blood-2022-165449

Published: 2022

Journal Articles

Therapeutic Targeting of EP300/CBP By Bromodomain Inhibition in Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 8774–8775.

https://doi.org/10.1182/blood-2022-166260

Published: 2022

Journal Articles

Integrative Analysis of Blast Phase Chronic Myelomonocytic Leukemia Reveals Distinct Transformation Phenotypes Predictive of Drug Response

Kristian Gurashi, Yu-Hung Wang, Tim C.P Somervaille, Kiran Batta, Daniel H Wiseman

Blood (2022) 140 (Supplement 1): 213–214.

https://doi.org/10.1182/blood-2022-168831

Published: 2022

Journal Articles

Multi-Omic Analysis of Chronic Myelomonocytic Leukaemia Monocytes Reveals Immune Dysregulation Mediated By TGF-β Activation

Hasse M Bossenbroek, Tim C.P Somervaille, Daniel H Wiseman, Kiran Batta

Blood (2021) 138 (Supplement 1): 2589.

https://doi.org/10.1182/blood-2021-152366

Published: 2021

Journal Articles

Multiomic Single-Cell Sequencing Reveals Patterns of Disease Evolution and Acute Transformation in Chronic Myelomonocytic Leukaemia

Kristian Gurashi, John Weightman, Syed M Baker, Kevin Rouault-Pierre, Wolfgang Breitweister, Tim C.P Somervaille, Kiran Batta, Daniel H Wiseman

Blood (2021) 138 (Supplement 1): 2586.

https://doi.org/10.1182/blood-2021-153540

Published: 2021

Journal Articles

Single-Cell Multi-Omics Defines the Cell-Type Specific Impact of SF3B1 Splicing Factor Mutations on Hematopoietic Differentiation in Human Clonal Hematopoiesis and Myelodysplastic Syndromes

Blood (2021) 138 (Supplement 1): 145.

https://doi.org/10.1182/blood-2021-147529

Published: 2021

Journal Articles

Vitamin B5 and Succinyl-CoA Improve Ineffective Erythropoiesis in SF3B1 Mutated Myelodysplasia

Syed Mian, Celine Philippe, Eleni Maniati, Tiffany Bergot, Marion Piganeau, Doriana Di Bella, Valle Morales, Andrew Finch, Katiuscia Bianchi, Jun Wang, Paolo Gallipoli, Uwe Platzbecker, Daniel H Wiseman, Dominique Bonnet, Delphine Bernard, John Gribben, Kevin Rouault-Pierre

Blood (2021) 138 (Supplement 1): 324.

https://doi.org/10.1182/blood-2021-147726

Published: 2021

NARROW

Incorporating TET2 Variant Allele Frequency Enhances Prognostication in CMML: Insights from 849 Patients across Multiple Institutions

Single-Cell Multiomic Profiling of TP53 Mutated Myelodysplastic Neoplasms - All Clones Are Not Equal

Granulocyte Derived Resistin Induces Classical Monocyte Repartition and Immune Suppression in CMML

Prediction Model to Evaluate Engraftment Kinetics Following Stem Cell Transplantation

Fungal Blood Stream Infections (BSI) in Hematology-Oncology Patients Have Worse Outcomes Than Solid Tumour Patients

Prevalence and Significance of Clonal Monocytosis of Undetermined Significance (CMUS) Amongst 431,531 United Kingdom Biobank Participants

Newly Developed Prognostic Score for Myelodysplastic Syndrome (MDS) with Isolated 5q Deletion (IPSS-del(5q))

Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion

HMR Mutations Drive Poor Prognosis in Myelofibrosis Patients with Lower JAK2 V617F Allele Burden but Not in Those with Higher Allele Burden: Results of a Multicenter Study

TP53 G ene a llelic State in Myelodysplastic Syndromes (MDS) with Isolated 5q Deletion

Development of Novel Protein-Drug Conjugates for the Treatment of Chronic Myelomonocytic Leukemia

Prognostic and Therapeutic Implications of TP53 expression in Chronic Myelomonocytic Leukaemia: Results of a Multicentre Study

The Functional and Molecular Alterations in Human Bone Marrow Mesenchymal Stem Cells in Chronic Myelomonocytic Leukemia

A Three Gene Leukemic Stem Cell Signature Score Is Robustly Prognostic in Chronic Myelomonocytic Leukemia

Therapeutic Targeting of EP300/CBP By Bromodomain Inhibition in Acute Myeloid Leukemia

Integrative Analysis of Blast Phase Chronic Myelomonocytic Leukemia Reveals Distinct Transformation Phenotypes Predictive of Drug Response

Multi-Omic Analysis of Chronic Myelomonocytic Leukaemia Monocytes Reveals Immune Dysregulation Mediated By TGF-β Activation

Multiomic Single-Cell Sequencing Reveals Patterns of Disease Evolution and Acute Transformation in Chronic Myelomonocytic Leukaemia

Single-Cell Multi-Omics Defines the Cell-Type Specific Impact of SF3B1 Splicing Factor Mutations on Hematopoietic Differentiation in Human Clonal Hematopoiesis and Myelodysplastic Syndromes

Vitamin B5 and Succinyl-CoA Improve Ineffective Erythropoiesis in SF3B1 Mutated Myelodysplasia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only